Artículo
A QM/MM study of the molecular recognition site of bapineuzumab toward the amyloid-β peptide isoforms
Gutierrez, Lucas Joel
; Barrera Guisasola, Exequiel Ernesto
; Peruchena, Nelida Maria
; Enriz, Ricardo Daniel
Fecha de publicación:
02/2016
Editorial:
Taylor & Francis Ltd
Revista:
Molecular Simulation
ISSN:
0892-7022
e-ISSN:
1029-0435
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
The molecular mechanism of recognition of amyloid-beta (Aβ) peptide isoforms by bapineuzumab was studied using a quantum mechanics and molecular mechanics (QM/MM) method. In this work, geometric optimisations were performed using the ONIOM2 scheme (at B3LYP/6-31G(d) amber)EE level) on the paratope of bapineuzumab together with the different forms of Aβ peptide (AβWT and AβN3(pE)). A comprehensive study of the interactions was also performed through Quantum Theory of Atoms in Molecules (QTAIM). This allowed us to obtain a deep understanding of how this antibody interacts with the amino acids of the Aβ peptides. The description on the interactions between bapineuzumab and the different forms of Aβ peptides allow us to understand why the peptides that lack the two first residues (Asp1 and Ala2) and begin with a pyroglutamate residue present low affinity for bapineuzumab. This basic structural information is useful for a deeper understanding about the scope and limitations of bapineuzumab as a therapeutic agent for the AD.
Palabras clave:
Alzheimers Disease
,
Amyloid-Beta Peptide
,
Oniom Calculations
,
Qtaim Analysis
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CCT - NORDESTE)
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - NORDESTE
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - NORDESTE
Articulos(IMIBIO-SL)
Articulos de INST. MULTIDICIPLINARIO DE INV. BIO. DE SAN LUIS
Articulos de INST. MULTIDICIPLINARIO DE INV. BIO. DE SAN LUIS
Citación
Gutierrez, Lucas Joel; Barrera Guisasola, Exequiel Ernesto; Peruchena, Nelida Maria; Enriz, Ricardo Daniel; A QM/MM study of the molecular recognition site of bapineuzumab toward the amyloid-β peptide isoforms; Taylor & Francis Ltd; Molecular Simulation; 42; 3; 2-2016; 196-207
Compartir
Altmétricas